Literature DB >> 23402389

The contribution of N₂O₃ to the cytotoxicity of the nitric oxide donor DETA/NO: an emerging role for S-nitrosylation.

Ahlam A Ali1, Jonathan A Coulter1, Claire H Ogle1, Marie M Migaud1, David G Hirst1, Tracy Robson1, Helen O McCarthy1.   

Abstract

The relationship between the biological activity of NO and its chemistry is complex. The objectives of this study were to investigate the influence of oxygen tension on the cytotoxicity of the NO• donor DETA/NO and to determine the effects of oxygen tension on the key RNS (reactive nitrogen species) responsible for any subsequent toxicity. The findings presented in this study indicate that the DETA/NO-mediated cytotoxic effects were enhanced under hypoxic conditions. Further investigations revealed that neither ONOO⁻ (peroxynitrite) nor nitroxyl was generated. Fluorimetric analysis in the presence of scavengers suggest for the first time that another RNS, dinitrogen trioxide may be responsible for the cytotoxicity with DETA/NO. Results showed destabilization of HIF (hypoxia inducible factor)-1α and depletion of GSH levels following the treatment with DETA/NO under hypoxia, which renders cells more susceptible to DETA/NO cytotoxicity, and could account for another mechanism of DETA/NO cytotoxicity under hypoxia. In addition, there was significant accumulation of nuclear p53, which showed that p53 itself might be a target for S-nitrosylation following the treatment with DETA/NO. Both the intrinsic apoptotic pathway and the Fas extrinsic apoptotic pathway were also activated. Finally, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) is another important S-nitrosylated protein that may possibly play a key role in DETA/NO-mediated apoptosis and cytotoxicity. Therefore this study elucidates further mechanisms of DETA/NO mediated cytotoxicity with respect to S-nitrosylation that is emerging as a key player in the signalling and detection of DETA/NO-modified proteins in the tumour microenvironment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23402389      PMCID: PMC3610299          DOI: 10.1042/BSR20120120

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  55 in total

1.  A discussion of the chemistry of oxidative and nitrosative stress in cytotoxicity.

Authors:  K M Miranda; M G Espey; D A Wink
Journal:  J Inorg Biochem       Date:  2000-04       Impact factor: 4.155

2.  The biotin switch method for the detection of S-nitrosylated proteins.

Authors:  S R Jaffrey; S H Snyder
Journal:  Sci STKE       Date:  2001-06-12

3.  NO-releasing NSAIDs suppress NF-κB signaling in vitro and in vivo through S-nitrosylation.

Authors:  Mitali Chattopadhyay; Satindra Goswami; Deborah B Rodes; Ravinder Kodela; Carlos A Velazquez; Daniel Boring; James A Crowell; Khosrow Kashfi
Journal:  Cancer Lett       Date:  2010-07-31       Impact factor: 8.679

4.  Ionizing radiation and nitric oxide donor sensitize Fas-induced apoptosis via up-regulation of Fas in human cervical cancer cells.

Authors:  In-Chul Park; Sang-Hyeok Woo; Myung-Jin Park; Hyung-Chahn Lee; Su-Jae Lee; Young-Joon Hong; Seung-Hoon Lee; Seok-Il Hong; Chang-Hun Rhee
Journal:  Oncol Rep       Date:  2003 May-Jun       Impact factor: 3.906

5.  Distinction between nitrosating mechanisms within human cells and aqueous solution.

Authors:  M G Espey; K M Miranda; D D Thomas; D A Wink
Journal:  J Biol Chem       Date:  2001-06-12       Impact factor: 5.157

6.  Fas-induced caspase denitrosylation.

Authors:  J B Mannick; A Hausladen; L Liu; D T Hess; M Zeng; Q X Miao; L S Kane; A J Gow; J S Stamler
Journal:  Science       Date:  1999-04-23       Impact factor: 47.728

7.  Nitric-oxide-induced necrosis and apoptosis in PC12 cells mediated by mitochondria.

Authors:  A Bal-Price; G C Brown
Journal:  J Neurochem       Date:  2000-10       Impact factor: 5.372

8.  JS-K, a nitric oxide-releasing prodrug, modulates ß-catenin/TCF signaling in leukemic Jurkat cells: evidence of an S-nitrosylated mechanism.

Authors:  Niharika Nath; Mitali Chattopadhyay; Liliya Pospishil; Lucyna Z Cieciura; Satindra Goswami; Ravinder Kodela; Joseph E Saavedra; Larry K Keefer; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2010-08-24       Impact factor: 5.858

9.  The reduction potential of nitric oxide (NO) and its importance to NO biochemistry.

Authors:  Michael D Bartberger; Wei Liu; Eleonora Ford; Katrina M Miranda; Christopher Switzer; Jon M Fukuto; Patrick J Farmer; David A Wink; Kendall N Houk
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

10.  Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins.

Authors:  H Kojima; N Nakatsubo; K Kikuchi; S Kawahara; Y Kirino; H Nagoshi; Y Hirata; T Nagano
Journal:  Anal Chem       Date:  1998-07-01       Impact factor: 6.986

View more
  7 in total

Review 1.  Erythropoietin and diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  World J Diabetes       Date:  2015-10-25

2.  Regeneration in the nervous system with erythropoietin.

Authors:  Kenneth Maiese
Journal:  Front Biosci (Landmark Ed)       Date:  2016-01

3.  The metal-nonoate Ni(SalPipNONO) inhibits in vitro tumor growth, invasiveness and angiogenesis.

Authors:  Valerio Ciccone; Martina Monti; Enrico Monzani; Luigi Casella; Lucia Morbidelli
Journal:  Oncotarget       Date:  2018-01-30

4.  Systemic RALA/iNOS Nanoparticles: A Potent Gene Therapy for Metastatic Breast Cancer Coupled as a Biomarker of Treatment.

Authors:  Cian M McCrudden; John W McBride; Joanne McCaffrey; Ahlam A Ali; Nicholas J Dunne; Vicky L Kett; Jonathan A Coulter; Tracy Robson; Helen O McCarthy
Journal:  Mol Ther Nucleic Acids       Date:  2016-12-31       Impact factor: 8.886

5.  Nitrosylation vs. oxidation - How to modulate cold physical plasmas for biological applications.

Authors:  Jan-Wilm Lackmann; Giuliana Bruno; Helena Jablonowski; Friederike Kogelheide; Björn Offerhaus; Julian Held; Volker Schulz-von der Gathen; Katharina Stapelmann; Thomas von Woedtke; Kristian Wende
Journal:  PLoS One       Date:  2019-05-08       Impact factor: 3.240

6.  Albumin is an interface between blood plasma and cell membrane, and not just a sponge.

Authors:  Jens van de Wouw; Jaap A Joles
Journal:  Clin Kidney J       Date:  2021-10-05

7.  Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer.

Authors:  Cian M McCrudden; John W McBride; Joanne McCaffrey; Emma M McErlean; Nicholas J Dunne; Vicky L Kett; Jonathan A Coulter; Tracy Robson; Helen O McCarthy
Journal:  Cancer Nanotechnol       Date:  2018-06-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.